Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostate Cancer Metastatic × pembrolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 108 Melanoma 79 Squamous Cell Carcinoma of Head and Neck 74 Breast Neoplasms 58 Triple Negative Breast Neoplasms 47 Head and Neck Neoplasms 38 Parkinson Disease 4, Autosomal Dominant Lewy Body 37 Ovarian Neoplasms 34 Colorectal Neoplasms 32 Neoplasm Metastasis 31 Stomach Neoplasms 30 Lung Neoplasms 30 Neoplasms 28 Carcinoma, Renal Cell 27 Urinary Bladder Neoplasms 24 Pancreatic Neoplasms 23 Carcinoma, Transitional Cell 21 Carcinoma, Hepatocellular 21 Recurrence 19 Hodgkin Disease 18 Uterine Cervical Neoplasms 17 Endometrial Neoplasms 17 Glioblastoma 16 Prostatic Neoplasms 15 Esophageal Neoplasms 15 Brain Neoplasms 15 Fallopian Tube Neoplasms 14 Carcinoma, Squamous Cell 14 Adenocarcinoma 13 Sarcoma 12

Interventions

enzalutamide 4 cabazitaxel 3 Docetaxel 3 Prednisone 2 talazoparib 1 rucaparib 1 pembrolizumab 1 olaparib 1 Zuclomiphene 1 XRP6258 1 Radiosurgery 1 Positron Emission Tomography Computed Tomography 1 LY3023414 1 Injections 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡